The Skin Diseases Research Center at the University of Wisconsin (UWSDRC) has collected 40 outstanding investigators from 16 Departments, 5 Schools and 7 Centers, all engaged in cutaneous cell death and differentiation research. The UW-Madison is an institution renowned for its academic environment which is conducive to innovative interdisciplinary approaches to biomedical research and education. All members of the UWSDRC have active research programs relevant to cutaneous biology and a broad range of skin diseases. UWSDRC investigators leverage $4.3M of annual direct support ($1.5M from NIAMS) to advance cutaneous cell death and differentiation research. The UWSDRC will be based in the Department of Dermatology to which the School of Medicine and Public Health made a major commitment when it recruited the proposed UWSDRC Director, Gary S. Wood, and Associate Director, Hasan Mukhtar. Major resources have been incorporated into Dermatology including departmental status, seven tenure-track faculty positions, 56,000 SF of space, start-up and retention packages, and more than $10M in endowments devoted exclusively to supporting research. Beginning with no extramural support in 2001, Dermatology has consistently ranked among the top 10-20 NIH skin disease research programs for several years. If the UWSDRC is funded, the Dean, UW Institute for Clinical and Translational Research (ICTR) and Department of Dermatology will commit an additional 1,600 SF of new space and up to $2.2M to supplement the NIH funds. The UWSDRC will contain an Administrative Core and 3 service cores (Cell Culture Core (CCC), Experimental Cutaneous Pathology Core (ECPC) and Evolving Technology Core (ETC)) as well as an Enrichment Program including pilot and feasibility studies, visiting professors, mentoring and gender/minority awareness. The UWSDRC will maximize performance and resources by coordinating with a wide array of existing UW-Madison core facilities and Department of Dermatology programs.
Skin diseases account for significant morbidity and mortality in the USA and worldwide. Creation of the Skin Diseases Research Center at the University of Wisconsin (UWSDRC) will provide important new resources to advance research and bring together 40 investigators from across the UW-Madison campus for greater collaboration in the fight against skin diseases.
|Erwin, Graham S; Grieshop, Matthew P; Ali, Asfa et al. (2017) Synthetic transcription elongation factors license transcription across repressive chromatin. Science 358:1617-1622|
|Garcia-Peterson, Liz Mariely; Ndiaye, Mary Ann; Singh, Chandra K et al. (2017) SIRT6 histone deacetylase functions as a potential oncogene in human melanoma. Genes Cancer 8:701-712|
|Gutteridge, Rosie Elizabeth Ann; Singh, Chandra K; Ndiaye, Mary Ann et al. (2017) Targeted knockdown of polo-like kinase 1 alters metabolic regulation in melanoma. Cancer Lett 394:13-21|
|Syed, Deeba N; Aljohani, Ahmed; Waseem, Durdana et al. (2017) Ousting RAGE in melanoma: A viable therapeutic target? Semin Cancer Biol :|
|Khan, Mohammad Imran; Rath, Suvasmita; Adhami, Vaqar Mustafa et al. (2017) Hypoxia driven glycation: Mechanisms and therapeutic opportunities. Semin Cancer Biol :|
|Rank, Leslie A; Walsh, Naomi M; Liu, Runhui et al. (2017) A Cationic Polymer That Shows High Antifungal Activity against Diverse Human Pathogens. Antimicrob Agents Chemother 61:|
|Rady, Islam; Siddiqui, Imtiaz A; Rady, Mohamad et al. (2017) Melittin, a major peptide component of bee venom, and its conjugates in cancer therapy. Cancer Lett 402:16-31|
|Chhabra, Gagan; Ndiaye, Mary Ann; Garcia-Peterson, Liz Mariely et al. (2017) Melanoma Chemoprevention: Current Status and Future Prospects. Photochem Photobiol 93:975-989|
|Salva, Katrin A; Reeder, Margo J; Lloyd, Rita et al. (2017) c-CBL E3 Ubiquitin Ligase Expression Increases Across the Spectrum of Benign and Malignant T-Cell Skin Diseases. Am J Dermatopathol 39:731-737|
|Meyers, Jordan M; Uberoi, Aayushi; Grace, Miranda et al. (2017) Cutaneous HPV8 and MmuPV1 E6 Proteins Target the NOTCH and TGF-? Tumor Suppressors to Inhibit Differentiation and Sustain Keratinocyte Proliferation. PLoS Pathog 13:e1006171|
Showing the most recent 10 out of 17 publications